Samsara BioCapital, LLC

Q4 2024 13F Holdings

  • Location
    palo alto, CA
  • Num holdings

    43

  • Value ($000)

    $728,583

  • Date Filed
    02/14/2025
  • Form type
    13F-HR
  • CIK
    0001744967
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
SRRK
SRRK

SCHOLAR ROCK HLDG CORP

COM
80706P103
$242.59M
33 %

5,612,896

CRGX
CRGX

CARGO THERAPEUTICS INC

COM
14179K101
$63.67M
9 %

4,415,689

---

SEPTERNA INC

COM
81734D104
$63.40M
9 %

2,768,520

MLYS
MLYS

MINERALYS THERAPEUTICS INC

COM
603170101
$62.47M
9 %

5,074,916

NGNE
NGNE

NEUROGENE INC

COM
64135M105
$39.25M
5 %

1,717,127

---

UPSTREAM BIO INC

COM
91678A107
$36.45M
5 %

2,217,146

LENZ
LENZ

LENZ THERAPEUTICS INC

COM
52635N103
$28.49M
4 %

986,981

ALMS
ALMS

ALUMIS INC

COM
022307102
$25.67M
4 %

3,266,498

ACLX
ACLX

ARCELLX INC

COMMON STOCK
03940C100
$19.45M
3 %

253,641

ZYME
ZYME

ZYMEWORKS INC

COM
98985Y108
$14.64M
2 %

1,000,000

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 43